Skip to content

Anti-D (IgG & IgM) Monoclonal

by Rapid Labs Ltd United Kingdom EUDAMED

Ref BG-D10Model Monoclonal EMDN W0103030201

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-05060599400358HK Basic UDI-DIDate22 Apr 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Model / Reference
Monoclonal, BG-D10
Primary DI / UDI-DI
D-05060599400358HK
Basic UDI-DI
B-05060599400358HK
EMDN Code
W0103030201 Rhesus d
Device Class
Class IVD Annex II List A
Market of Registration
Poland

Manufacturer details

EUDAMED SRN
GB-MF-000026335
Authorised representative
Advena Limited MT-AR-000000234

Other devices from Rapid Labs Ltd

See all devices from Rapid Labs Ltd →

Properties & raw data

Show properties, registry sources and raw records
  • Human Tissues
  • Reagent
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED 27fa855d-59c4-4e9b-adb3-97bd141d064e 61 fields · synced 22 Oct 2026